% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • mmazza333 mmazza333 Sep 28, 2013 5:40 PM Flag

    Conclusion of SA article 9-28-13


    Galena experienced many positive developments in the past few quarters, including acquiring an FDA approved drug and advancement of its clinical trials. With the acquisition of Abstral, Galena will become a commercial organization. During the commercialization of Abstral, Galena will get a chance to build a relationship in the market that is beneficial for promoting its promising pipeline.

    Now, the most legitimate question in the mind of investors is what is the outlook of Galena as an investment? We believe that by acquiring the FDA approved Abstral and the market potential of NeuVax, the outlook for Galena is bright, and the company will outperform in the foreseeable future.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.7799+0.0244(+3.23%)Feb 12 4:00 PMEST